79
Views
3
CrossRef citations to date
0
Altmetric
Methodology

Pharmacogenetic testing revisited: 5′ nuclease real-time polymerase chain reaction test panels for genotyping CYP2D6 and CYP2C19

&
Pages 115-128 | Published online: 18 Apr 2017

References

  • KoskiAOjanperäISistonenJVuoriESajantilaAA fatal doxepin poisoning associated with a defective CYP2D6 genotypeAm J Forensic Med Pathol200728325926117721180
  • OguCCMaxaJLDrug interactions due to cytochrome P450Proc (Bayl Univ Med Cent)200013442142316389357
  • PougetJGShamsTATiwariAKMüllerDJPharmacogenetics and outcome with antipsychotic drugsDialogues Clin Neurosci201416455556625733959
  • JürgensGJacobsenCBRasmussenHBWergeTNordentoftMAndersenSEUtility and adoption of CYP2D6 and CYP2C19 genotyping and its translation into psychiatric clinical practiceActa Psychiatr Scand2012125322823722128793
  • RavynDRavynVLowneyRNasrallahHACYP450 pharmacogenetic treatment strategies for antipsychotics: a review of the evidenceSchizophr Res20131491–311423870808
  • StreetmanDSBertinoJSJrNafzigerANPhenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probesPharmacogenetics200010318721610803676
  • JuricaJBartecekRZourkovaASerum dextromethorphan/dextrorphan metabolic ratio for CYP2D6 phenotyping in clinical practiceJ Clin Pharm Ther201237448649022548589
  • LynchTPriceAThe effect of cytochrome P450 metabolism on drug response, interactions, and adverse effectsAm Fam Physician200776339139617708140
  • ArnethBShamsMHiemkeCHärtterSRapid and reliable genotyping procedure for detection of alleles with mutations, deletion, or/ and duplication of the CYP2D6 geneClin Biochem200942121282129019393232
  • SakuyamaKSasakiTUjiieSFunctional characterization of 17 CYP2D6 allelic variants (CYP2D6.2, 10, 14A–B, 18, 27, 36, 39, 47–51, 53–55, and 57)Drug Metab Dispos200836122460246718784265
  • HosonoNKatoMKiyotaniKCYP2D6 genotyping for functional-gene dosage analysis by allele copy number detectionClin Chem20095581546155419541866
  • BenSCooper-DeHoffRMFlatenHKMultiplex SNaPshot-a new simple and efficient CYP2D6 and ADRB1 genotyping methodHum Genomics2016101127108086
  • McElroySSachseCBrockmollerJCYP2D6 genotyping as an alternative to phenotyping for determination of metabolic status in a clinical trial settingAAPS PharmSci200024E3311741249
  • CaudleKEKleinTEHoffmanJMIncorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development processCurr Drug Metab201415220921724479687
  • SpinaEde LeonJClinical applications of CYP genotyping in psychiatryJ Neural Transm (Vienna)2015122152825200585
  • ZhouSFLiuJPChowbayBPolymorphism of human cytochrome P450 enzymes and its clinical impactDrug Metab Rev20094128929519514967
  • KleinKTatzelSRaimundoSA natural variant of the heme-binding signature (R441C) resulting in complete loss of function of CYP2D6Drug Metab Dispos20073581247125017460029
  • SachseCBrockmöllerJHildebrandMMüllerKRootsICorrectness of prediction of the CYP2D6 phenotype confirmed by genotyping 47 intermediate and poor metabolizers of debrisoquinePharmacogenetics19988218118510022755
  • ShamsMEArnethBHiemkeCCYP2D6 polymorphism and clinical effect of the antidepressant venlafaxineJ Clin Pharm Ther200631549350216958828
  • SteimerWZöpfKvon AmelunxenSAmitriptyline or not, that is the question: pharmacogenetic testing of CYP2D6 and CYP2C19 identifies patients with low or high risk for side effects in amitriptyline therapyClin Chem200551237638515590749
  • JohanssonILundqvistEBertilssonLDahlMLSjöqvistFIngelman-SundbergMInherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquineProc Natl Acad Sci U S A1993902411825118297903454
  • GhasemiZHashemiMEjabatiMDevelopment of a high-resolution melting analysis method for CYP2C19*17 genotyping in healthy volunteersAvicenna J Med Biotechnol20168419319927920888
  • Ingelman-SundbergMGenetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversityPharmacogenomics J20055161315492763
  • DoradoPCáceresMCPozo-GuisadoEWongMLLicinioJLlerenaADevelopment of a PCR-based strategy for CYP2D6 genotyping including gene multiplication of worldwide potential useBiotechniques200539457157416235570
  • SistonenJFuselliSPaloJUChauhanNPadhHSajantilaAPharmacogenetic variation at CYP2C9, CYP2C19, and CYP2D6 at global and microgeographic scalesPharmacogenet Genomics200919217017919151603
  • GaedigkAComplexities of CYP2D6 gene analysis and interpretationInt Rev Psychiatry201325553455324151800
  • SimSCIngelman-SundbergMThe Human Cytochrome P450 (CYP) Allele Nomenclature website: a peer-reviewed database of CYP variants and their associated effectsHum Genomics20104427828120511141
  • BlackJL3rdWalkerDLO’KaneDJHarmandayanMFrequency of undetected CYP2D6 hybrid genes in clinical samples: impact on phenotype predictionDrug Metab Dispos201240111111922004686
  • StromCMGoosDCrossleyBTesting for variants in CYP2C19: population frequencies and testing experience in a clinical laboratoryGenet Med20121419510022237437
  • HicksJKSwenJJThornCFClinical Pharmacogenetics Implementation ConsortiumClinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressantsClin Pharmacol Ther201393540240823486447
  • WiitaASchrijverIClinical application of high throughput molecular screening techniques for pharmacogenomicsPharmgenomics Pers Med2011410912123226057
  • RebsamenMCDesmeulesJDaaliYThe AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype predictionPharmacogenomics J200991344118591960
  • BankPCSwenJJGuchelaarHJvan der StraatenTGenoChip CYP2D6 macroarray as a method to genotype for CYP2D6 variants: results of a validation study in a Caucasian populationPharmacogenomics201516768168725929855
  • HiratsukaMAgatsumaYOmoriFHigh throughput detection of drug metabolizing enzyme polymorphisms by allele specific fluorogenic 5′ nuclease chain reaction assayBiol Pharm Bull200023101131113511041238
  • RoijersJFJansen-HoutepenLJakobsBSvan WijkEMDetection of the CYP2D6*6 allele by LightCycler real-time PCRNed Tijdschr Klin Chem Labgeneesk2007324270272
  • NielsenKAHansenELGilleSGenotyping of the cytochrome P450 2D6 4469 C>T polymorphism using SimpleProbesÔScand J Clin Lab Invest200767328029017454842
  • RasmussenJOChristensenMSvendsenJMSkausigOHansenELNielsenKACYP2D6 gene test in psychiatric patients and healthy volunteersScand J Clin Lab Invest200666212913616537246
  • PindurováEZourkováAZrůstováJJuřicaJPavelkaAAlternative reliable method for cytochrome P450 2D6 poor metabolizers genotypingMol Biotechnol2013531294022367691
  • ChangYSLeeCCLiuTYChenYCLuHCChangJGDirect assessment of cytochrome P450 2D6 genotypes by high-resolution melting analysis and DNA sequencingEnviron Toxicol Pharmacol201438382182825461541
  • KalendarRLeeDSchulmanAHFastPCR software for PCR primer and probe design and repeat searchGenes Genomes Genomics200931114
  • SchaeffelerESchwabMEichelbaumMZangerUMCYP2D6 genotyping strategy based on gene copy number determination by TaqMan real-time PCRHum Mutat200322647648514635107
  • RaimundoSToscanoCKleinKA novel intronic mutation, 2988G>A, with high predictivity for impaired function of cytochrome P450 2D6 in white subjectsClin Pharmacol Ther200476212813815289790
  • ToscanoCKleinKBlievernichtJImpaired expression of CYP2D6 in intermediate metabolizers carrying the *41 allele caused by the intronic SNP 2988G>A: evidence for modulation of splicing eventsPharmacogenet Genomics2006161075576617001295
  • KimuraSUmenoMSkodaRCMeyerUAGonzalezFJThe human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogeneAm J Hum Genet19894568899042574001
  • NelsonDRZeldinDCHoffmanSMMaltaisLJWainHMNebertDWComparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variantsPharmacogenetics200414111815128046
  • SistonenJSajantilaALaoOCoranderJBarbujaniGFuselliSCYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structurePharmacogenet Genomics20071729310117301689
  • SachseCBrockmöllerJBauerSRootsICytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequencesAm J Hum Genet19976022842959012401
  • GaedigkAGarcia-RiberaCJeongHEShinJGHernandez-SanchezJResolution of a clinical AmpliChip CYP450 TestÔ no call: discovery and characterization of novel CYP2D6*1 haplotypesPharmacogenomics20141591175118425141893
  • MelisRLyonEMcMillinGADetermination of CYP2D6, CYP2C9 and CYP2C19 genotypes with Tag-It mutation detection assaysExpert Rev Mol Diagn20066681182017140368
  • DodgenTMHochfeldWEFicklHIntroduction of the AmpliChip CYP450 Test to a South African cohort: a platform comparative prospective cohort studyBMC Med Genet2013142023356658
  • Cavalli-SforzaLLBodmerWFThe genetics of human populationsLivingstoneFBAmerican Journal of Physical Anthropology39San FranciscoW. H. Freeman1971965
  • GaedigkASangkuhlKWhirl-CarrilloMKleinTLeederJSPrediction of CYP2D6 phenotype from genotype across world populationsGenet Med2017191697627388693
  • LuHCChangYSChangCCLinCHChangJGDeveloping and evaluating the HRM technique for identifying cytochrome P450 2D6 polymorphismsJ Clin Lab Anal201529322022524798984
  • PanseratSMuraCGérardNDNA haplotype-dependent differences in the amino acid sequence of debrisoquine 4-hydroxylase (CYP2D6): evidence for two major allozymes in extensive metabolisersHum Genet19949444014067927337
  • RaimundoSFischerJEichelbaumMGrieseEUSchwabMZangerUMElucidation of the genetic basis of the common “intermediate metabolizer” phenotype for drug oxidation by CYP2D6Pharmacogenetics200010757758111037799
  • GaedigkAFreemanNHartshorneTSNP genotyping using TaqMan technology: the CYP2D6*17 assay conundrumSci Rep20155925725788121
  • GaedigkARiffelAKBerrocalBGSolaesaVGDávilaIIsidoro-GarcíaMCharacterization of a complex CYP2D6 genotype that caused an AmpliChip CYP450 Test no-call in the clinical settingClin Chem Lab Med201452679980724445243
  • PrattVMZehnbauerBWilsonJACharacterization of 107 genomic DNA reference materials for CYP2D6, CYP2C19, CYP2C9, VKORC1, and UGT1A1: a GeT-RM and Association for Molecular Pathology collaborative projectJ Mol Diagn201012683584620889555
  • The Human Cytochrome P450 (CYP) Allele Nomenclature Database Available from: http://www.cypalleles.ki.se/cyp2d6.htmAccessed March 13, 2017